|
|
|
|
Predictor factors associated with liver fibrosis and steatosis by transient elastography in HIV mono-infected patients under long-term combined antiretroviral therapy
|
|
|
from Jules: fatty liver in HIV+ is a concern that has yet to get much attention & recognition. CAP is a measure by doing Fibroscan of fat in the liver (steatosis) & LSM measures Fibrosis also by doing Fibroscan. This study reported duration cART is associated with fatty liver (steatosis), and so are central obesity, dyslipidemia and diabetes, and history of AZT use, and duration of having HIV.
Reported by Jules Levin
9th IAS Conference on HIV Science (IAS 2017), July 23-26, 2017, Paris
Hugo Perazzo, Sandra W Cardoso, Carolyn Yanavich, João Carlos Soares, Juliana Fittipaldi, Michelle Morata, Claudia Cardoso, Paula Simplicio, Cristiane de Almeida, Valdilea G Veloso, Beatriz Grinsztejn
National Institute of Infectious Diseases Evandro Chagas (INI)
Oswaldo Cruz Foundation (FIOCRUZ)
Rio de Janeiro - Brazil
|
|
|
|
|
|
|